Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients
Clinical trial NCT01832857 · TERMINATED
Trial details
- NCT number
- NCT01832857
- Sponsor
- Cornerstone Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.